Steady Growth
Impressive growth trajectory for Brisbane company
Ready to scale
Verging on commercialisation, the perfect time to invest is today

WearOptimo Timeline

Key company and product milestones

Tracking a path to commercialisation through partnerships, technology and investment


First B2B Sales Expected

WearOptimo are delighted to announce our partnership with the Queensland Government, The Australian National University (ANU), The Australian National Fabrication Facility (ANFF), and others in a $30 million project. This project will support the production of our world-leading, lifesaving MicrowearableTM technology at a new Queensland facility which will be key in creating hundreds of high-value jobs throughout this decade. This project aligns with the government’s Queensland Biomedical 10-Year Roadmap and Action Plan to make Queensland a globally competitive Asia-Pacific biomedical hub by 2027.

Current Investment round

Validation trials, manufacturing capability, product refinement


Nanoimprint Lithography Commission

Nanoimprint Lithography Commission



Wearable hydration sensor detects small fluid shifts in the body 


Human Pilot Trials

Commenced First Human Pilot trials of Prototype Hydration Microwearable

Pictured (from left to right) - Professor Mark Kendall (Founder and CEO of WearOptimo), Professor Brian Schmidt (Vice-Chancellor of The Australian National University), and Glenn Keys (Aspen Medical Founder and Executive Chairman).

Aspen Medical: takes $4M equity stake & commercial distribution partner


Patent Granted

Hydration Microwearable patent granted in Australia


Prototype Developed

Prototype wireless Hydration Microwearable sensor developed


WearOptimo Founded

WearOptimo founded


Foundation Partner

Foundational Partner: ANU Investment: $6M initial - $11M to date